Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Research analysts at Roth Capital issued their FY2024 earnings estimates for shares of Curaleaf in a research report issued on Sunday, November 10th. Roth Capital analyst W. Kirk anticipates that the company will post earnings of ($0.26) per share for the year. Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Roth Capital also issued estimates for Curaleaf’s Q4 2024 earnings at ($0.07) EPS, Q1 2025 earnings at ($0.06) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.05) EPS, Q4 2025 earnings at ($0.04) EPS and FY2025 earnings at ($0.21) EPS.
Other equities analysts have also recently issued research reports about the company. Cormark cut Curaleaf from a “moderate buy” rating to a “hold” rating in a research note on Thursday, November 7th. Needham & Company LLC reaffirmed a “buy” rating and set a $6.25 price objective on shares of Curaleaf in a research report on Thursday, August 8th.
Curaleaf Stock Up 9.8 %
OTCMKTS:CURLF opened at $2.24 on Wednesday. The business’s fifty day moving average price is $2.92 and its 200 day moving average price is $3.74. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of -7.72 and a beta of 0.86. The company has a current ratio of 1.11, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. Curaleaf has a 1-year low of $1.64 and a 1-year high of $6.40.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Stories
- Five stocks we like better than Curaleaf
- Using the MarketBeat Dividend Tax Calculator
- Rocket Lab is the Right Stock for the Right Time
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
